| Novartis Pharma Schweiz AG - Revolade 75 mg, Filmtabletten | | 60122 | | 06 | | Revolade 75 mg | | Filmtabletten | | B02BX05 | | Eltrombopag | | 08.05.2018 | | |
| | Composition | | eltrombopagum 75 mg ut eltrombopagum olaminum, mannitolum, cellulosum microcristallinum, povidonum K 30, carboxymethylamylum natricum A corresp. natrium 0.784-1.176 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | | BAG: Active Agent | Dose |
|---|
| | 75 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | | | | | Mannitol | | | | | 30 | | | | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 006 | 28 | 2993.81 | 3272.35 | A | SL | No |
|
|
